CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, announced the launch of its new line of bioinks for 3D bioprinting. The new bioinks are designed to be biocompatible and versatile, making them ideal for a wide range of applications, including 3D biological model construction and cultivation, tissue engineering, and drug delivery.
CD Bioparticles launched a range of hydrophobic interaction chromatography resins for the purification of macromolecules including adeno-associated viruses.
CD Bioparticles launched a variety of strong and weak Ion Exchange Magnetic Particles to separate proteins, peptides, antibodies, DNA/RNA, and other biomolecules.
CD Bioparticles launched a range of near-infra-red (NIR) quantum dots that exhibit excellent optical properties and biocompatibility for biomedical imaging.
CD Bioparticles launches Carboxyl PEG3000 Gold Nanoparticles for covalent conjugation of antibodies, proteins and other ligands using standard EDC/NHS coupling chemistry.
CD Bioparticles introduces a series of Heparins products to support drug delivery research, such as the Heparin Biotin, Heparin Amine, and Heparin Thiol.
CD Bioparticles now launches a series of highly-monodisperse spherical titania nanoparticles (Titania Aqueous Dispersion and Titania Ethanol Dispersion).
CD Bioparticles launches custom upconverting nanoparticles conjugation service using various types of upconverting nanoparticles to conjugate with antibodies.
CD Bioparticles expands its Metal Organic Frameworks (MOFs) materials portfolio with the launch of Zinc-based MOFs (Fe-MOF) to support drug delivery studies for the research communities.
CD Bioparticles introduces carbon-based nanocages production services to global researchers for R&D and commercialization in a variety of applications.
Satisfied Users & 
Approved Press Releases
